A new molecular scissors act like a GPS to improve genome editing
Researchers from the University of Copenhagen (Denmark), led by the Spanish researcher Guillermo Montoya, have discovered how Cpf1, a new molecular scissors unzip and cleave DNA. This member of the CRISPR-Cas family displays a high accuracy, capable of acting like a GPS in order to identify its destination within the intricate map of the genome. The high precision of Cpf1 will improve the use of this type of technology in repairing genetic damage and in other medical and biotechnological applications.
A scientific team from in the Novo Nordisk Foundation Center for Protein Research (NNF-CPR), at the University of Copenhagen, has succeeded in visualizing and describing how a new system for genome editing, known as Cpf1, works. This protein belongs to the Cas family and enables the cleavage of double stranded DNA, thus allowing the initiation of the genome modification process. The results of the study have been published in the journal Nature.
Guillermo Montoya, a researcher in the fields of biochemistry and molecular biology who led the study, explains to SINC that the new molecular scissors “will enable us to more safely modify and edit the instructions written in the genome, due to the utmost precision of the target DNA sequence recognition”.
The new molecular scissors achieve complementary ends instead of blunt, as happens with Cas9, which facilitates the insertion of a DNA sequence
The CRISPR Cas9 system for cutting and paste genome sequences is already being used to modify animal and plant genomes. Also to treat illnesses, such as cancer and retinal diseases, in humans and its applications are growing very fast.
X-Ray Crystallography Technique
Researchers across the world are trying to perfect this genome editing technique with the aim of making it yet more precise and efficient. To achieve this, they have also focused on other proteins that specifically cut DNA, such as Cpf1, whose manipulation can direct them to specific locations in the genome. Montoya’s team has achieved this using an X-ray Crystallography to decipher the molecular mechanisms controlling this process.
“We radiated the crystals of the Cpf1 protein using X-rays to be able to observe its structure at atomic resolution, enabling us to see all its components,” points out the co-author of this study. “X-ray diffraction is one of the main biophysical techniques used to elucidate biomolecular structures,” he continues.
In his opinion, “the main advantage of Cpf1 lies in its high specificity and the cleaving mode of the DNA, since it is possible to create staggered ends with the new molecular scissors, instead of blunt-ended breaks as is the case with Cas9, which facilitates the insertion of a DNA sequence.”
“The high precision of this protein recognising the DNA sequence on which it is going to act functions like a GPS, directing the Cpf1 system within the intricate map of the genome to identify its destination. In comparison with other proteins used for this purpose, it is also very versatile and easy to be reprogrammed,” Montoya adds.
The high precision DNA sequence recognition functions as a GPS that directs the tool within the intricate map of the genome
Genetic diseases and tumours
These properties make this system “particularly suitable for its use in the treatment of genetic diseases and tumours,” he affirms.
The team has previously worked with the French biotechnology company Celletics on the use of meganucleases –other proteins that can be redesigned to cut the genome in a specific location– to treat certain types of leukemia.
The new technology “can also be used to modify microorganisms, with the aim of synthesising the metabolites required in the production of drugs and biofuels,” adds Montoya.
This researcher, from Getxo (Biscay, Spain), says that there are many companies interested in this new technology. They are mostly from the biotechnology sector in the field of microorganism manipulation, but cannot be named due to confidentiality agreements.
The Latest on: Genome editing
- New genome editing technology for plant breedingon July 19, 2019 at 5:36 am
Researchers have developed a new genome editing technology for rice, combining adenine-to-guanine single-base editing technology and Cas9 with an extended targeting scope. They report that it is ... […]
- Biotech building facility to make genome-edited, off-the-shelf CAR-T therapieson July 18, 2019 at 6:41 am
RELATED: French biotech Cellectis picks U.S. for commercial CAR-T production While there are other companies working in this area, Precision is built around Arcus, a genome editing platform that uses ... […]
- Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management - Future Market Insightson July 18, 2019 at 6:05 am
The growing prevalence and incidence of rare genetic disorders, majorly Sickle Cell Disease (SKD), cancer, and Alzheimer's disease, is leading to the high demand for genome editing, and is one of the ... […]
- Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United Stateson July 18, 2019 at 3:30 am
DURHAM, N.C., July 18, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS ... […]
- Guidelines established for editing human genomeon July 18, 2019 at 3:17 am
TOKYO >> The Japanese government has established guidelines for genome editing technology for human embryos. The guidelines, instituted April 1 by the education and health ministries, stipulate that ... […]
- Genome Editing Market Expected to Expand at a High CAGR By End of 2026on July 17, 2019 at 6:53 am
Jul 17, 2019 (Global QYResearch via COMTEX) -- Globalqyresearch.com has announced the addition of a new research study on the “Global Genome Editing Market Size, Status and Forecast 2019-2026” to its ... […]
- Market Insights of Genome Editing Market by Top Key Companies, Size , Key Findings And Regional Outlookon July 17, 2019 at 2:37 am
Jul 17, 2019 (AmericaNewsHour) -- This market research report includes a detailed segmentation of the global genome editing market - by technology (CRISPR, TALEN, ZFN, and Others), by application ... […]
- Better genome editing for bioenergyon July 16, 2019 at 5:35 am
CRISPR-Cas9 is a powerful, high-throughput gene-editing tool that can help scientists engineer organisms for bioenergy applications. Cas9 needs guide RNA to lead it to the correct sequence to snip ... […]
- Evogene amends Bayer partnership to target gene editing for corn diseaseson July 16, 2019 at 5:11 am
Evogene Ltd. (NASDAQ:EVGN) has amended its corn disease resistance research collaboration with Bayer's (OTCPK:BAYRY) Crop Science Division to focus on identifying genome editing targets that may ... […]
- Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targetson July 16, 2019 at 4:10 am
Amended agreement follows positive results in corn stalk rot fungal disease control REHOVOT, Israel, July 16, 2019 /PRNewswire/ -- Evogene Ltd. (EVGN) (EVGN), a leading biotechnology company ... […]
via Google News and Bing News